Principia Biopharma Inc. (PRNB) financial statements (2023 and earlier)

Company profile

Business Address 220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments315,580176,925
Cash and cash equivalents39,53734,489
Short-term investments276,043142,436
Restricted cash and investments 82
Prepaid expense2,8931,661
Other undisclosed current assets1,2722,104
Total current assets:319,745180,772
Noncurrent Assets
Property, plant and equipment9,6871,666
Long-term investments and receivables52,2573,712
Long-term investments52,2573,712
Restricted cash and investments567567
Other noncurrent assets4808,804
Total noncurrent assets:62,99114,749
TOTAL ASSETS:382,736195,521
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,1679,744
Accounts payable1,8504,439
Accrued liabilities602993
Employee-related liabilities6,7154,312
Deferred rent credit1,181 
Other undisclosed current liabilities5,7917,136
Total current liabilities:16,13916,880
Noncurrent Liabilities
Liabilities, other than long-term debt7,6198,781
Deferred rent credit7,6198,781
Total noncurrent liabilities:7,6198,781
Total liabilities:23,75825,661
Stockholders' equity
Stockholders' equity attributable to parent358,978169,860
Common stock32
Additional paid in capital544,709302,393
Accumulated other comprehensive income (loss)9(128)
Accumulated deficit(185,743)(132,407)
Total stockholders' equity:358,978169,860
TOTAL LIABILITIES AND EQUITY:382,736195,521

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
Revenues35,16069,137
Gross profit:35,16069,137
Operating expenses(93,925)(51,995)
Operating income (loss):(58,765)17,142
Nonoperating income4,9731,025
Investment income, nonoperating4,9731,678
Other nonoperating expense (653)
Income (loss) from continuing operations before income taxes:(53,792)18,167
Income tax expense (1)
Income (loss) before gain (loss) on sale of properties:(53,792)18,166
Other undisclosed net income 1
Net income (loss) attributable to parent:(53,792)18,167
Undistributed earnings (loss) allocated to participating securities, basic (13,250)
Net income (loss) available to common stockholders, diluted:(53,792)4,917

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
Net income (loss):(53,792)18,167
Comprehensive income (loss):(53,792)18,167
Other undisclosed comprehensive income (loss), net of tax, attributable to parent137(38)
Comprehensive income (loss), net of tax, attributable to parent:(53,655)18,129

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: